98%
921
2 minutes
20
Purpose: In a unit practicing minimally invasive pancreatic necrosectomy (MIPN), our aim was to assess whether tomographic residual necrotic volume was an objective indicator for repeat necrosectomy.
Methods: Prospective study of acute pancreatitis admissions. Patients with infected pancreatic necrosis or deteriorating sepsis had MIPN. Outcome parameters included necrotic volumes, conversion rate, morbidity, and mortality.
Results: Thirty patients were admitted with acute pancreatitis of which 15 required organ support. Twenty-nine necrosectomy sessions were performed. Average time from admission to necrosectomy was 39.7 days with an internecrosectomy interval of 6 to 14 days. Mean reduction of necrosis volume was 89.5% and postnecrosectomy volumes were variable. Mean length of hospital and intensive care unit stay was 124.3 and 40.2 days, respectively. Complications included bleeding, pancreatic fistula, and gastric outlet obstruction. No in-hospital deaths or conversions occurred.
Conclusion: Frequent MIPN achieves substantial pancreatic bed volume reduction with no conversions. Repetitive tomographic scanning is of limited use as an indicator for renecrosectomy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/SLE.0b013e31821e5e6e | DOI Listing |
Am J Surg Pathol
August 2025
Department of Pathology and Laboratory Medicine.
Neoadjuvant chemotherapy plays a vital role in the treatment of pancreatic ductal adenocarcinoma (PDAC), but treatment effect complicates pathologic examination of postneoadjuvant Whipple resections. Institutional practice is variable but current Pancreatobiliary Pathology Society (PBPS) guidelines suggest extensive microscopic examination of the tumor bed (TB). In practice, gross identification of TB is challenging and may lead to an inaccurate assessment of tumor size.
View Article and Find Full Text PDFKaku Igaku
August 2025
Department of Nuclear Medicine, Faculty of Medicine, Medical, Pharmaceutical and Health Sciences, Kanazawa University.
Purpose: Radionuclide therapy often involve long waiting periods due to limited numbers of radioisotope therapy rooms and special measures rooms, and strict regulations. The purpose of this study was to estimate the waiting period for radionuclide therapy, considering the increased utilization of nuclear medicine and greater demand due to new drugs. The study also examined possible factors that may limit the treatment provision system and investigate appropriate treatment environments that could shorten the waiting period.
View Article and Find Full Text PDFBackground: Pancreatic cancer remains one of the most aggressive and lethal malignancies, with particularly poor prognoses in the elderly. Recent research has highlighted the role for lifestyle factors, including sleep, in cancer prognosis. This study aimed to evaluate the effect of sleep duration and quality, as measured by wearable smart devices, on the prognosis of pancreatic cancer in the elderly.
View Article and Find Full Text PDFJAMA Netw Open
July 2025
Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic Rochester, Rochester, Minnesota.
Importance: Identification of factors associated with variation in outpatient surgery may further quality improvement efforts to safely reduce postoperative hospital length of stay nationally.
Objectives: To explore variation in the use of outpatient surgery, incorporating patient, geographic, and hospital factors.
Design, Setting, And Participants: This retrospective cross-sectional study used deidentified administrative claims data from OptumLabs Data Warehouse.
Gastroenterol Hepatol Bed Bench
January 2025
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pancreatic cancer (PC) remains one of the most formidable malignancies, with survival rates showing minimal improvement over the years despite progress in chemotherapy, targeted treatments, and radiation therapy. The development of targeted agents and chemotherapy for cancer treatment has only moderately influenced clinical results and has not significantly altered 5-year survival rates. However, with the rapid discovery of the genetic and molecular functions underlying PC, new opportunities for targeted therapies are emerging.
View Article and Find Full Text PDF